Gut Microbial Metabolites of Aromatic Amino Acids as Signals in Host–Microbe Interplay

Trends in Endocrinology and Metabolism

Volumn 31, Issue 11, 2020, Pages 818-834

  Liu, Yali ^a   Hou, Yuanlong ^a   Wang, Guangji ^a   Zheng, Xiao ^a   Hao, Haiping ^a  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

aromatic amino acids; host microbe interaction; microbial metabolism; signaling metabolites

Indexed keywords

AROMATIC AMINO ACID; BACTERIAL ENZYME;

AMINO ACID METABOLISM; BACTERIAL METABOLISM; CARDIOVASCULAR DISEASE; CENTRAL NERVOUS SYSTEM DISEASE; GASTROINTESTINAL DISEASE; HOST MICROBE INTERACTION; HOST RESISTANCE; HUMAN; INTESTINE FLORA; KIDNEY DISEASE; LIVER DISEASE; MICROBIAL METABOLISM; NONHUMAN; PHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; GASTROINTESTINAL TRACT; METABOLISM; MICROBIOLOGY;

AMINO ACIDS, AROMATIC; ANIMALS; GASTROINTESTINAL MICROBIOME; GASTROINTESTINAL TRACT; HUMANS;

EID: 85083007403     PISSN: 10432760     EISSN: 18793061     Source Type: Journal    
DOI: 10.1016/j.tem.2020.02.012     Document Type: Review

References (89)

1. Gordon, J.I., Honor thy gut symbionts redux. Science 336 (2012), 1251–1253.
2. Schroeder, B., Backhed, F., Signals from the gut microbiota to distant organs in physiology and disease. Nat. Med. 22 (2016), 1079–1089.
3. Jia, W., et al. Bile acid-microbiota crosstalk in gastrointestinal inflammation and carcinogenesis. Nat. Rev. Gastroenterol. Hepatol. 15 (2018), 111–128.
4. Sanna, S., et al. Causal relationships among the gut microbiome, short-chain fatty acids and metabolic diseases. Nat. Genet. 51 (2019), 600–605.
5. Nicholson, J.K., et al. Host-gut microbiota metabolic interactions. Science 336 (2012), 1262–1267.
6. Cervenka, I., et al. Kynurenines: tryptophan's metabolites in exercise, inflammation, and mental health. Science, 357, 2017, eaaf9794.
7. Schuck, P.F., et al. Phenylketonuria pathophysiology: on the role of metabolic alterations. Aging Dis. 6 (2015), 390–399.
8. Bortolato, M., et al. Monoamine oxidase inactivation: from pathophysiology to therapeutics. Adv. Drug Deliv. Rev. 60 (2008), 1527–1533.
9. Dodd, D., et al. A gut bacterial pathway metabolizes aromatic amino acids into nine circulating metabolites. Nature 551 (2017), 648–652.
10. Saito, Y., et al. Identification of phenol- and p-cresol-producing intestinal bacteria by using media supplemented with tyrosine and its metabolites. FEMS Microbiol. Ecol., 94, 2018, fiy125.
11. Xiang, L., Moore, B.S., Biochemical characterization of a prokaryotic phenylalanine ammonia lyase. J. Bacteriol. 187 (2005), 4286–4289.
12. Whiting, G.C., Carr, J.G., Metabolism of cinnamic acid and hydroxy-cinnamic acids by Lactobacillus pastorianus var. quinicus. Nature 184 (1959), 1427–1428.
13. Agus, A., et al. Gut microbiota regulation of tryptophan metabolism in health and disease. Cell Host Microbe 23 (2018), 716–724.
14. Lee, J.H., et al. Roles of indole as an interspecies and interkingdom signaling molecule. Trends Microbiol. 23 (2015), 707–718.
15. Visconti, A., et al. Interplay between the human gut microbiome and host metabolism. Nat. Commun., 10, 2019, 4505.
16. Williams, B.B., et al. Discovery and characterization of gut microbiota decarboxylases that can produce the neurotransmitter tryptamine. Cell Host Microbe 16 (2014), 495–503.
17. Roager, H.M., Licht, T.R., Microbial tryptophan catabolites in health and disease. Nat. Commun., 9, 2018, 3294.
18. Cervantes-Barragan, L., et al. Lactobacillus reuteri induces gut intraepithelial CD4(+)CD8alphaalpha(+) T cells. Science 357 (2017), 806–810.
19. Hou, Q., et al. Lactobacillus accelerates ISCs regeneration to protect the integrity of intestinal mucosa through activation of STAT3 signaling pathway induced by LPLs secretion of IL-22. Cell Death Differ. 25 (2018), 1657–1670.
20. Venkatesh, M., et al. Symbiotic bacterial metabolites regulate gastrointestinal barrier function via the xenobiotic sensor PXR and Toll-like receptor 4. Immunity 41 (2014), 296–310.
21. Alexeev, E.E., et al. Microbiota-derived indole metabolites promote human and murine intestinal homeostasis through regulation of interleukin-10 receptor. Am. J. Pathol. 188 (2018), 1183–1194.
22. Chimerel, C., et al. Bacterial metabolite indole modulates incretin secretion from intestinal enteroendocrine L cells. Cell Rep. 9 (2014), 1202–1208.
23. Bhattarai, Y., et al. Gut microbiota-produced tryptamine activates an epithelial G-protein-coupled receptor to increase colonic secretion. Cell Host Microbe 23 (2018), 775–785.
24. Krishnan, S., et al. Gut microbiota-derived tryptophan metabolites modulate inflammatory response in hepatocytes and macrophages. Cell Rep. 23 (2018), 1099–1111.
25. Jaglin, M., et al. Indole, a signaling molecule produced by the gut microbiota, negatively impacts emotional behaviors in rats. Front. Neurosci., 12, 2018, 216.
26. Peters, A., et al. Metabolites of lactic acid bacteria present in fermented foods are highly potent agonists of human hydroxycarboxylic acid receptor 3. PLoS Genet., 15, 2019, e1008145.
27. Espinoza, S., et al. Functional interaction between trace amine-associated receptor 1 and dopamine D2 receptor. Mol. Pharmacol. 80 (2011), 416–425.
28. Fernandez de Palencia, P., et al. Role of tyramine synthesis by food-borne Enterococcus durans in adaptation to the gastrointestinal tract environment. Appl. Environ. Microbiol. 77 (2011), 699–702.
29. Gainetdinov, R.R., et al. Trace amines and their receptors. Pharmacol. Rev. 70 (2018), 549–620.
30. Zucchi, R., et al. Trace amine-associated receptors and their ligands. Br. J. Pharmacol. 149 (2006), 967–978.
31. Santoru, M.L., et al. Cross sectional evaluation of the gut–microbiome metabolome axis in an Italian cohort of IBD patients. Sci. Rep., 7, 2017, 9523.
32. Jansson, J., et al. Metabolomics reveals metabolic biomarkers of Crohn's disease. PLoS ONE, 4, 2009, e6386.
33. Jacobs, J.P., et al. A disease-associated microbial and metabolomics state in relatives of pediatric inflammatory bowel disease patients. Cell Mol. Gastroenterol. Hepatol. 2 (2016), 750–766.
34. Yachida, S., et al. Metagenomic and metabolomic analyses reveal distinct stage-specific phenotypes of the gut microbiota in colorectal cancer. Nat. Med. 25 (2019), 968–976.
35. Gryp, T., et al. p-Cresyl sulfate. Toxins (Basel), 2017, 52–59.
36. Al Hinai, E.A., et al. Modelling the role of microbial p-cresol in colorectal genotoxicity. Gut Microbes 10 (2018), 398–411.
37. Nikolaus, S., et al. Increased tryptophan metabolism is associated with activity of inflammatory bowel diseases. Gastroenterology 153 (2017), 1504–1516.
38. Lamas, B., et al. CARD9 impacts colitis by altering gut microbiota metabolism of tryptophan into aryl hydrocarbon receptor ligands. Nat. Med. 22 (2016), 598–605.
39. Zelante, T., et al. Tryptophan catabolites from microbiota engage aryl hydrocarbon receptor and balance mucosal reactivity via interleukin-22. Immunity 39 (2013), 372–385.
40. Islam, J., et al. Dietary tryptophan alleviates dextran sodium sulfate-induced colitis through aryl hydrocarbon receptor in mice. J. Nutr. Biochem. 42 (2017), 43–50.
41. Wlodarska, M., et al. Indoleacrylic acid produced by commensal Peptostreptococcus species suppresses inflammation. Cell Host Microbe 22 (2017), 25–37.
42. Boursier, J., et al. The severity of nonalcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota. Hepatology 63 (2016), 764–775.
43. Natividad, J.M., et al. Impaired aryl hydrocarbon receptor ligand production by the gut microbiota is a key factor in metabolic syndrome. Cell Metab. 28 (2018), 737–749.
44. Manna, S.K., et al. UPLC-MS-based urine metabolomics reveals indole-3-lactic acid and phenyllactic acid as conserved biomarkers for alcohol-induced liver disease in the Ppara-null mouse model. J. Proteome Res. 10 (2011), 4120–4133.
45. Wang, J., et al. Gut microbial dysbiosis is associated with altered hepatic functions and serum metabolites in chronic hepatitis B patients. Front. Microbiol., 8, 2017, 2222.
46. Hoyles, L., et al. Molecular phenomics and metagenomics of hepatic steatosis in non-diabetic obese women. Nat. Med. 24 (2018), 1070–1080.
47. Yang, T., et al. The gut microbiota and the brain-gut-kidney axis in hypertension and chronic kidney disease. Nat. Rev. Nephrol. 14 (2018), 442–456.
48. Devlin, A.S., et al. Modulation of a circulating uremic solute via rational genetic manipulation of the gut microbiota. Cell Host Microbe 20 (2016), 709–715.
49. Meijers, B., et al. Intestinal microbiome and fitness in kidney disease. Nat. Rev. Nephrol. 15 (2019), 531–545.
50. Jankowski, J., et al. Increased plasma phenylacetic acid in patients with end-stage renal failure inhibits iNOS expression. J. Clin. Investig. 112 (2003), 256–264.
51. Shivanna, S., et al. The aryl hydrocarbon receptor is a critical regulator of tissue factor stability and an antithrombotic target in uremia. J. Am. Soc. Nephrol. 27 (2016), 189–201.
52. Brown, J.M., Hazen, S.L., Microbial modulation of cardiovascular disease. Nat. Rev. Microbiol. 16 (2018), 171–181.
53. Tzoulaki, I., et al. Serum metabolic signatures of coronary and carotid atherosclerosis and subsequent cardiovascular disease. Eur. Heart J. 40 (2019), 2883–2896.
54. Cason, C.A., et al. Plasma microbiome-modulated indole- and phenyl-derived metabolites associate with advanced atherosclerosis and postoperative outcomes. J. Vasc. Surg. 68 (2018), 1552–1562.
55. Lam, V., et al. Intestinal microbial metabolites are linked to severity of myocardial infarction in rats. PLoS ONE, 11, 2016, e0160840.
56. Virtue, A.T., et al. The gut microbiota regulates white adipose tissue inflammation and obesity via a family of microRNAs. Sci. Transl. Med., 11, 2019, eaav1892.
57. Laurans, L., et al. Genetic deficiency of indoleamine 2,3-dioxygenase promotes gut microbiota-mediated metabolic health. Nat. Med. 24 (2018), 1113–1120.
58. Wilck, N., et al. Salt-responsive gut commensal modulates TH17 axis and disease. Nature 551 (2017), 585–589.
59. Yau-Jan Chyan, B.P., et al. Potent neuroprotective properties against the Alzheimer b-amyloid by an endogenous melatonin-related indole structure, indole-3-propionic acid. J. Biol. Chem. 274 (1999), 21937–21942.
60. Rothhammer, V., et al. Microglial control of astrocytes in response to microbial metabolites. Nature 557 (2018), 724–728.
61. Rothhammer, V., et al. Type I interferons and microbial metabolites of tryptophan modulate astrocyte activity and central nervous system inflammation via the aryl hydrocarbon receptor. Nat. Med. 22 (2016), 586–597.
62. Chen, H., et al. A forward chemical genetic screen reveals gut microbiota metabolites that modulate host physiology. Cell 177 (2019), 1217–1231.
63. Anderson, G.M., et al. Central tryptamine turnover in depression, schizophrenia, and anorexia: measurement of indoleacetic acid in cerebrospinal fluid. Biol. Psychiatry 19 (1984), 1427–1435.
64. Yao, J.K., et al. Altered interactions of tryptophan metabolites in first-episode neuroleptic-naive patients with schizophrenia. Mol. Psychiatry 15 (2010), 938–953.
65. Berry, M.D., et al. Pharmacology of human trace amine-associated receptors: therapeutic opportunities and challenges. Pharmacol. Ther. 180 (2017), 161–180.
66. Navarro, H.A., et al. A rapid functional assay for the human trace amine-associated receptor 1 based on the mobilization of internal calcium. J. Biomol. Screen. 11 (2006), 688–693.
67. Skelly, A.N., et al. Mining the microbiota for microbial and metabolite-based immunotherapies. Nat. Rev. Immunol. 19 (2019), 305–323.
68. Cohen, L.J., et al. Commensal bacteria make GPCR ligands that mimic human signalling molecules. Nature 549 (2017), 48–53.
69. Suez, J., Elinav, E., The path towards microbiome-based metabolite treatment. Nat. Microbiol., 2, 2017, 17075.
70. Roberts, A.B., et al. Development of a gut microbe-targeted nonlethal therapeutic to inhibit thrombosis potential. Nat. Med. 24 (2018), 1407–1417.
71. Lam, K.N., et al. Precision medicine goes microscopic: engineering the microbiome to improve drug outcomes. Cell Host Microbe 26 (2019), 22–34.
72. Cryan, J.F., et al. A microbial drugstore for motility. Cell Host Microbe 23 (2018), 691–692.
73. Colosimo, D.A., et al. Mapping interactions of microbial metabolites with human G-protein-coupled receptors. Cell Host Microbe 26 (2019), 273–282.
74. Maldonado-Gomez, M.X., et al. Stable engraftment of Bifidobacterium longum AH1206 in the human gut depends on individualized features of the resident microbiome. Cell Host Microbe 20 (2016), 515–526.
75. He, Y., et al. Regional variation limits applications of healthy gut microbiome reference ranges and disease models. Nat. Med. 24 (2018), 1532–1535.
76. Vandeputte, D., et al. Practical considerations for large-scale gut microbiome studies. FEMS Microbiol. Rev. 41 (2017), S154–S167.
77. Pessione, E., et al. First evidence of a membrane-bound, tyramine and beta-phenylethylamine producing, tyrosine decarboxylase in Enterococcus faecalis: a two-dimensional electrophoresis proteomic study. Proteomics 9 (2009), 2695–2710.
78. Aoki, R., et al. Indole-3-pyruvic acid, an aryl hydrocarbon receptor activator, suppresses experimental colitis in mice. J. Immunol. 201 (2018), 3683–3693.
79. Russell, W.R., et al. Major phenylpropanoid-derived metabolites in the human gut can arise from microbial fermentation of protein. Mol. Nutr. Food Res. 57 (2013), 523–535.
80. Smith, E.A., Macfarlane, G.T., Enumeration of human colonic bacteria producing phenolic and indolic compounds: effects of pH, carbohydrate availability and retention time on dissimilatory aromatic amino acid metabolism. J. Appl. Bacteriol. 81 (1996), 288–302.
81. Elsden, S.R., et al. The end products of the metabolism of aromatic amino acids by Clostridia. Arch. Microbiol. 107 (1976), 283–288.
82. Yang, X., et al. Improving 3-phenyllactic acid production of Lactobacillus plantarum AB-1 by enhancing its quorum-sensing capacity. J. Food Sci. Technol. 56 (2019), 2605–2610.
83. Dickert, S., et al. The involvement of coenzyme A esters in the dehydration of (R)-phenyllactate to (E)-cinnamate by Clostridium sporogenes. Eur. J. Biochem. 267 (2000), 3874–3884.
84. Noda, S., et al. Cinnamic acid production using Streptomyces lividans expressing phenylalanine ammonia lyase. J. Ind. Microbiol. Biotechnol. 38 (2011), 643–648.
85. Liu, W.H., et al. Indole-3-acetic acid in Burkholderia pyrrocinia JK-SH007: enzymatic identification of the indole-3-acetamide synthesis pathway. Front. Microbiol., 10, 2019, 2559.
86. Aragozzini, F., et al. Indole-3-lactic acid as a tryptophan metabolite produced by Bifidobacterium spp. Appl. Environ. Microbiol. 38 (1979), 544–546.
87. Debnar-Daumler, C., et al. Simultaneous involvement of a tungsten-containing aldehyde:ferredoxin oxidoreductase and a phenylacetaldehyde dehydrogenase in anaerobic phenylalanine metabolism. J. Bacteriol. 196 (2014), 483–492.
88. Parthasarathy, A., et al. A three-ring circus: metabolism of the three proteogenic aromatic amino acids and their role in the health of plants and animals. Front. Mol. Biosci., 5, 2018, 29.
89. Nyangale, E.P., et al. Gut microbial activity, implications for health and disease: the potential role of metabolite analysis. J. Proteome Res. 11 (2012), 5573–5585.